Company Overview
- Headquarters
- 16305 36Th Ave N, Minneapolis MN
- Website
- celcuity.com
- Phone
- (763) 392-0767
- Employees
- 82
- Founded in
- 2012
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 541 CompaniesNAICS Code 32 CompaniesNAICS Code 325 CompaniesNAICS Code 54 CompaniesNAICS Code 3254 CompaniesNAICS Code 32541 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$8B
Total Funding Amount
$55M
Who is Celcuity
Celcuity is a clinical-stage biotechnology company headquartered in Minneapolis, Minnesota. The company employs 82 individuals and generates approximately $8.2 million in annual revenue. Celcuity focuses on developing innovative therapies and diagnostic tools for cancer patients. Their primary therapeutic candidate, gedatolisib, is a dual inhibitor targeting PI3K and mTOR, aiming to extend the lives of cancer patients. Celcuity's CELsignia companion diagnostic platform analyzes live tumor cells to identify patients who may benefit from existing targeted therapies. Celcuity's gedatolisib boasts a unique mechanism of action and pharmacokinetic properties, differentiating it from other therapies targeting PI3K or mTOR. The company anticipates initiating a Phase 3 study evaluating gedatolisib in patients with HR+/HER2- advanced breast cancer in 2022. For more information about Celcuity and its groundbreaking work, visit www.celcuity.com.
Company Leadership
Celcuity Industry Tags
Companies Similar to Celcuity
Analyze industry trends and opportunities by examining competitors and companies comparable to Celcuity, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 8M | 45 | New Castle, DE | 1990 | |
| 8M | 19 | Pleasanton, CA | 2007 | |
| 8M | 77 | Irvine, CA | 2009 | |
| 8M | 2 | East Walpole, MA | 2015 | |
| 8M | 33 | Cardiff by the Sea, CA | 2016 |